Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Oncoprotein 18
(
Op18
) is a cytosolic protein that was initially identified due to its up-regulated expression in acute leukemia and its complex pattern of phosphorylation in response to diverse extracellular signals. We have previously identified in vivo phosphorylation sites and some of the protein kinase systems involved. Two distinct proline-directed kinase families phosphorylate Ser25 and Ser38 of
Op18
with overlapping but distinct site preference. These two kinase families, mitogen-activated protein (MAP) kinases and cyclin-dependent cdc2 kinases, are involved in receptor-regulated and cell-cycle-regulated phosphorylation events, respectively. During analysis of
Op18
phosphorylation in the Jurkat T-cell line, we also found that Ser16 of
Op18
is phosphorylated in response to a Ca2+ signal generated by T-cell receptor stimulation or the Ca2+ ionophore ionomycin. As suggested by a previous study, T-cell-receptor-induced phosphorylation events may be mediated by the Ca2+/CaM-dependent protein kinase type Gr (
CaM kinase
-Gr). The present study shows that activation of this protein kinase correlates with phosphorylation of Ser16 of
Op18
, and in vitro experiments reveal efficient and selective phosphorylation of this residue. The
CaM kinase
-Gr is only expressed in certain lymphoid cell lines, and the present study shows that ionomycin-induced phosphorylation of
Op18
Ser16 is restricted to cells expressing this protein kinase. Finally,
CaM kinase
-Gr-dependent in vitro phosphorylation of a crude cellular extract reveals a striking preference of this protein kinase for
Op18
compared to other cellular substrates. In conclusion, the results suggest that Ser16 of
Op18
is a major cytosolic target for activated
CaM kinase
-Gr.
...
PMID:Serine 16 of oncoprotein 18 is a major cytosolic target for the Ca2+/calmodulin-dependent kinase-Gr. 792 72
We investigated specific signaling events initiated after T cell triggering through the costimulatory surface receptors CD2 and CD28 as compared with activation via the Ag receptor (TCR/CD3). We therefore followed the phosphorylation of
stathmin
, a ubiquitous cytoplasmic phosphoprotein proposed as a general relay integrating diverse intracellular signaling pathways through the combinatorial phosphorylation of serines 16, 25, 38, and 63, the likely physiologic substrates for Ca2+/calmodulin (CaM)-dependent kinases, mitogen-activated protein (MAP) kinase, cyclin-dependent kinases (cdks), and protein kinase A, respectively. We addressed the specific protein kinase systems involved in the CD2 pathway of T cell activation through the analysis of
stathmin
phosphorylation patterns in exponentially growing Jurkat T cells, as revealed by phosphopeptide mapping. Stimulation via CD2 activated multiple signal transduction pathways, resulting in phosphorylation of distinct sites of
stathmin
, the combination of which only partially overlaps the CD3- and CD28-induced patterns. The partial redundancy of the three T cell activation pathways was evidenced by the phosphorylation of Ser25 and Ser38, substrates of MAP kinases and of the cdk family kinase(s), respectively. Conversely, the phosphorylation of Ser16 of
stathmin
was observed in response to both CD2 and CD28 triggering, but not CD3 triggering, with a kinetics compatible with the lasting activation of
CaM kinase II
in response to CD2 triggering. In vitro, Ser16 of recombinant human
stathmin
was phosphorylated also by purified
CaM kinase II
, and in vivo,
CaM kinase II
activity was indeed stimulated in CD2-triggered Jurkat cells. Altogether, our results favor an association of
CaM kinase II
activity with costimulatory signals of T lymphocyte activation and phosphorylation of
stathmin
on Ser16.
...
PMID:Serine 16 of stathmin as a cytosolic target for Ca2+/calmodulin-dependent kinase II after CD2 triggering of human T lymphocytes. 968 69
Stathmin is a ubiquitous cytosolic phosphoprotein, preferentially expressed in the nervous system, and the generic element of a protein family that includes the neural-specific proteins SCG10, SCLIP, and RB3 and its splice variants, RB3' and RB3". All phosphoproteins of the family share with
stathmin
its tubulin binding and microtubule (MT)-destabilizing activities. To understand better the specific roles of these proteins in neuronal cells, we performed a comparative study of their expression, regulation, and intracellular distribution in embryonic cortical neurons in culture. We found that
stathmin
is highly expressed ( approximately 0.25% of total proteins) and uniformly present in the various neuronal compartments (cell body, dendrites, axon, growth cones). It appeared mainly unphosphorylated or weakly phosphorylated on one site, and antisera to specific phosphorylated sites (serines 16, 25, or 38) did not reveal a differential regulation of its phosphorylation among neuronal cell compartments. However, they revealed a subpopulation of cells in which
stathmin
was highly phosphorylated on serine 16, possibly by
CaM kinase II
also active in a similar subpopulation. The other proteins of the
stathmin
family are expressed about 100-fold less than
stathmin
in partially distinct neuronal populations, RB3 being detected in only about 20% of neurons in culture. In contrast to
stathmin
, they are each mostly concentrated at the Golgi apparatus and are also present along dendrites and axons, including growth cones. Altogether, our results suggest that the different members of the
stathmin
family have complementary, at least partially distinct functions in neuronal cell regulation, in particular in relation to MT dynamics.
...
PMID:Regulation and subcellular localization of the microtubule-destabilizing stathmin family phosphoproteins in cortical neurons. 1211 43
The regulation of microtubule dynamics is important for the appropriate arborization of neuronal dendrites during development, which in turn is critical for the formation of functional neural networks. Here we show that
stathmin
, a microtubule destabilizing factor, is downregulated at both the expression and activity levels during cerebellar development, and this down-regulation contributes to dendritic arborization. Stathmin overexpression drastically limited the dendritic growth of cultured Purkinje cells. The
stathmin
activity was suppressed by neural activity and
CaMKII
-dependent phosphorylation at Ser16, which led to dendritic arborization. Stathmin phosphorylation at Ser16 was mediated by the activation of voltage-gated calcium channels and metabotropic glutamate receptor 1. Although overexpression of SCG10, a member of the
stathmin
family, also limited the dendritic arborization, SCG10 did not mediate the
CaMKII
regulation of dendritic development. These results suggest that calcium elevation activates
CaMKII
, which in turn phosphorylates
stathmin
at Ser16 to stabilize dendritic microtubules. siRNA knockdown of endogenous
stathmin
significantly reduced dendritic growth in Purkinje cells. Thus, these data suggest that proper regulation of
stathmin
activity is a key factor for controlling the dendritic microtubule dynamics that are important for neuronal development.
...
PMID:The microtubule destabilizer stathmin mediates the development of dendritic arbors in neuronal cells. 1738 83